Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT01971593
Eligibility Criteria:
Inclusion Criteria:
* Established diagnosis of tetralogy of Fallot, transposition of the great vessels with a systemic right ventricle, or Fontan type palliation
* Patient followed regularly at Washington University-affiliated institution
* If female, willing to use 2 forms of contraception including one barrier method during protocol
Exclusion Criteria:
* GFR \<30 ml/min
* Potassium \>5.0 mmol/L
* Unable or unwilling to comply with study protocol
* Use of potassium sparing diuretics
* Use of an aldosterone blocker currently or previously
* Known intolerance of eplerenone or aldosterone blockade
* Pregnant, breastfeeding, or actively trying to get pregnant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01971593
Study Brief:
Protocol Section:
NCT01971593